Correlation Between Syndax Pharmaceuticals and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Lyra Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Lyra Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Lyra Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Syndax and Lyra is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Lyra Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 5.45 times less return on investment than Lyra Therapeutics. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 1.91 times less risky than Lyra Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 17.00 in Lyra Therapeutics on October 20, 2024 and sell it today you would earn a total of 2.00 from holding Lyra Therapeutics or generate 11.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Lyra Therapeutics
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Lyra Therapeutics |
Syndax Pharmaceuticals and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Lyra Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |